BioSpace News Archive

Limbix today announced Benjamin Alouf, M.D., chief medical officer of Limbix, will present clinical data demonstrating the efficacy of SparkRx in adolescents with moderate to severe depressive symptoms at the upcoming American Academy of Pediatrics (AAP) National Conference. The virtual conference begins Oct. 8.

Horizon Therapeutics plc Announces New UPLIZNA ® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2021

Solid Biosciences Inc. and Forge Biologics announced a partnership to advance the development and manufacturing of SGT-003, Solid’s next generation gene therapy program for Duchenne.

Halo Labs, a life science instrumentation company developing tools for biologics researchers, today announced it has launched its latest product, Aura GT.

VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, announced that members of the management team will participate in analyst-led fireside chats at the following upcoming investor conferences.

The Vaccine Against Canine Cancer Study trial reported its formal two-year evaluation of the safety of a vaccine to prevent cancer in healthy dogs.

Ambrx today announced that NovoCodex Pharmaceuticals Ltd. presented positive interim data from the ACE-Gastric-01 Phase 1 clinical study of ARX788 for the treatment of HER2+ metastatic gastric / gastroesophageal junction (GEJ) cancer at The Chinese Society of Clinical Oncology (CSCO).

Imperative Care, Inc. announced today that the first patient has been enrolled in the Imperative Trial.

The 27th annual BIO-Europe global life sciences partnering event will be held October 25-28, 2021 in a fully digital format.

TriLink BioTechnologies announced that it expects to supply its proprietary CleanCap® mRNA capping technology and the modified nucleoside, uridine triphosphate, to EyeGene, Inc. for production of EyeGene’s mRNA COVID-19 vaccine, EG-COVID, which recently received approval to begin clinical trials from the South Korean Ministry of Food and Drug Safety.